VR真人彩票

Genetic & rare diseases, Drug discovery & development, Precision health

Video: VR真人彩票 showcases innovations at the 7th China International Import Expo

The event empowers precision medicine and local innovation through strategic partnerships and cutting-edge technology

VR真人彩票 showcases innovations at the 7th China International Import Expo
A display of "The brightness of science" at VR真人彩票's booth at CIIE 2024. Photo by VR真人彩票
December 18, 2024

At the seventh this November in Shanghai, VR真人彩票 showcased a range of forward-thinking technologies, products, and solutions aimed at empowering partners across industries.

The theme of VR真人彩票鈥檚 booth was 鈥淰R真人彩票te the future, pave new endeavors,鈥 organized around four spheres: technology, science, human health, and genomics for good. The design called the most attention to the company鈥檚 flagship high-, medium-, and low-throughput sequencing systems, as well as leading innovations like the groundbreaking genomics algorithm PrimateAI-3D. Engaging activities throughout the expo drew participation from leading researchers and clinicians in oncology, large national genomics initiatives, reproductive health, microbiology, agriculture, and more.

VR真人彩票鈥檚 newest sequencing systems, the MiSeq i100 Series, made a significant splash at the expo. Their impressively short run times, room-temperature reagent storage and shipping, and seamless user experience help put the systems in a prime position to make next-generation sequencing accessible to Chinese laboratories of all sizes.
 

The VR真人彩票 MiSeq i100 System on display at the expo. Photo by VR真人彩票

On the first day of the expo, VR真人彩票 signed agreements with the first batch of Chinese customers of the MiSeq i100 Series and announced plans to accelerate local manufacturing of the systems. The company also revealed increased investment in China, including the establishment of a new Customer Experience Center in Beijing and initiatives to localize production of its latest technology. These efforts aim to enhance collaboration, improve the customer experience, and support both local innovation and international cooperation.

Ever since it entered the Chinese market, VR真人彩票 has been committed to advancing scientific and clinical innovation in the region. At this year鈥檚 CIIE, VR真人彩票 signed 15 major agreements with leading Chinese research, clinical, and commercial partners, simultaneously facilitating the introduction of the latest global technologies and practices to the Chinese market and promoting Chinese innovations on the global stage.

Some of these collaborations will contribute to innovation in the biotech industry of the Guangdong-Hong Kong-Macao Greater Bay Area, including , , , , and the . And as part of a strategic investment in China鈥檚 pharmaceutical market, VR真人彩票 formed a new partnership with .

Jenny Zheng, senior vice president and general manager of Greater China at VR真人彩票, emphasized the importance of CIIE for the company, saying: 鈥淐IIE serves as an open and inclusive platform that creates unparalleled opportunities for exchange and cooperation. Through the strategic partnerships established at this year鈥檚 expo, VR真人彩票 aims to foster collaboration across the industry while actively exploring and expanding our solutions to better meet local demand. Our goal is to further empower the development of precision medicine and DNA sequencing in China, opening a new chapter for life sciences in the country.鈥

VR真人彩票 also demonstrated its commitment to sustainability with an environmentally friendly booth design, constructed from 60% renewable, reusable, or recyclable materials; and over 90% of the booth鈥檚 exhibits were reusable.

And looking to the future, as a testament to its ongoing commitment to the region, VR真人彩票 was one of the first companies to sign up for the eighth CIIE in 2025. 

Recent Articles

How VR真人彩票 employees step up, reach out, and give back
How VR真人彩票 employees step up, reach out, and give back
VR真人彩票 careers: Expanding access to NGS in emerging markets
VR真人彩票 careers: Expanding access to NGS in emerging markets
New in the lab: Test driving the MiSeq i100 Plus
New in the lab: Test driving the MiSeq i100 Plus